Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis
- PMID: 39760239
- DOI: 10.1111/all.16466
Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis
Abstract
Introduction: Chronic hand eczema (CHE) is a highly prevalent inflammatory skin condition which is often resistant to conventional treatments. Molecular insights of CHE remain limited. Tape stripping combined with high-throughput RNA sequencing can now provide a better insight into CHE pathogenesis in a minimally invasive fashion.
Methods: We collected tape strip samples from lesional and non-lesional skin of 66 patients with moderate-to-severe CHE, comprising 33 with and 33 without comorbid atopic dermatitis (AD), and performed bulk RNA sequencing. Results were compared to tape strips from palmar skin of age/race/sex-matched healthy controls (HC). Differentially expressed genes (DEGs) (fold change/FCH > 1.5 and false discovery rate/FDR < 0.05) were calculated and correlated with clinical severity scores including hand eczema severity index (HECSI) and modified total lesion symptoms score (mTLSS).
Results: Tape strip isolates detected a common phenotype in CHE lesions regardless of AD status, including upregulated type-1 (IL12RB2, IFNGR1, IFNGR2, MX1) and type-2-associated inflammatory mediators (CCL22, CCL24, OX40/TNFRSF4, TSLPR/CRLF2, GATA3), paralleled by downregulated epidermal barrier markers (i.e., FLG or LORICRIN). Non-lesional skin demonstrated a similar, albeit milder, dysregulation pattern, with additional reduction in type-17 pathways. Lesional skin of CHE patients without AD showed greater skewing towards type-1 immunity (IL15RA, CXCL9), while CHE from AD patients showed a more pronounced type-2 inflammatory pattern (IL13, CCL17) and their gene expression biomarkers had greater and more significant correlations with clinical severity markers.
Conclusion: Tape stripping can capture detailed immune and skin barrier abnormalities in CHE and identify potential novel subtype-specific treatment targets. Stronger correlations in patients with AD suggest a more homogenous disease phenotype than in CHE non-AD patients.
Trial registration: NCT03728504.
Keywords: RNA sequencing; atopic dermatitis; chronic hand eczema; skin biomarkers; tape strips.
© 2025 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
-
- T. Agner and P. Elsner, “Hand Eczema: Epidemiology, Prognosis and Prevention,” Journal of the European Academy of Dermatology and Venereology 34, no. Suppl 1 (2020): 4–12.
-
- J. P. Thyssen, J. D. Johansen, A. Linneberg, and T. Menne, “The Epidemiology of Hand Eczema in the General Population – Prevalence and Main Findings,” Contact Dermatitis 62, no. 2 (2010): 75–87.
-
- L. Scalone, P. A. Cortesi, L. G. Mantovani, et al., “Clinical Epidemiology of Hand Eczema in Patients Accessing Dermatological Reference Centres: Results From Italy,” British Journal of Dermatology 172, no. 1 (2015): 187–195.
-
- A. S. Quaade, A. B. Simonsen, A. S. Halling, J. P. Thyssen, and J. D. Johansen, “Prevalence, Incidence, and Severity of Hand Eczema in the General Population ‐ A Systematic Review and Meta‐Analysis,” Contact Dermatitis 84, no. 6 (2021): 361–374.
-
- L. Wold, J. K. Chen, and H. P. Lampel, “Hand Dermatitis: An Allergist's Nightmare,” Current Allergy and Asthma Reports 14, no. 11 (2014): 474.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
